MDMA (drug)-drug interactions influence CYP3A4 expression via PXR-mediator

被引：0
|
作者：
Lobo, I. Antolino
Maas-Bakker, R. [1 ]
Meijerman, I. [1 ]
Meulenbelt, J.
Van den Berg, M.
Van Duursen, M.
机构：
[1] Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Utrecht, Netherlands
来源：
TOXICOLOGY LETTERS | 2010年 / 196卷
关键词：
D O I：
10.1016/j.toxlet.2010.03.854
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：S256 / S256
页数：1
相关论文
共 50 条
  • [1] Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development
    Sinz, Michael W.
    DRUG METABOLISM REVIEWS, 2013, 45 (01) : 3 - 14
  • [2] Utility of CYP3A4 and PXR-CAR-CYP3A4/3A7 Transgenic Mouse Models To Assess the Magnitude of CYP3A4 Mediated Drug-Drug Interactions
    Ly, Justin Q.
    Messick, Kirsten
    Qin, Ann
    Takahashi, Ryan H.
    Choo, Edna F.
    MOLECULAR PHARMACEUTICS, 2017, 14 (05) : 1754 - 1759
  • [3] Comparison of CYP3A4 and CYP3A5 in Drug Metabolism and Drug Interactions
    Li, Shuanmei
    Liu, Duan
    Zhu, Juanli
    Cui, Yan
    Zhou, Ruimin
    Chen, Chao
    DRUG METABOLISM REVIEWS, 2009, 41 : 31 - 32
  • [4] The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
    Lehmann, JM
    McKee, DD
    Watson, MA
    Willson, TM
    Moore, JT
    Kliewer, SA
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (05): : 1016 - 1023
  • [5] QUANTITATIVE PREDICTION OF CYP3A4 AND CYP3A5-MEDIATED DRUG DRUG INTERACTIONS
    Guo, Yingying
    Lucksiri, Aroonrut
    Dickinson, Gemma
    Vuppalanchi, Raj
    Hilligoss, Janna
    Huang, Shiew-Mei
    Hall, Stephen
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S43 - S44
  • [6] Homotropic and heterotropic cooperativity of CYP3A4 and drug-drug interactions
    Denisov, Ilia G.
    Frank, Daniel
    Grinkova, Yelena V.
    Sligar, Stephen G.
    FASEB JOURNAL, 2008, 22
  • [7] In vitro interactions of abiraterone, erythromycin, and CYP3A4: implications for drug-drug interactions
    Masamrekh, Rami A.
    Kuzikov, Alexey V.
    Haurychenka, Yaraslau I.
    Shcherbakov, Kirill A.
    Veselovsky, Alexander V.
    Filimonov, Dmitrii A.
    Dmitriev, Alexander V.
    Zavialova, Maria G.
    Gilep, Andrei A.
    Shkel, Tatsiana V.
    Strushkevich, Natallia V.
    Usanov, Sergey A.
    Archakov, Alexander I.
    Shumyantseva, Victoria V.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2020, 34 (01) : 120 - 130
  • [8] Use of a Physiologically Based Pharmacokinetic Model for Quantitative Prediction of Drug-Drug Interactions via CYP3A4 and Estimation of the Intestinal Availability of CYP3A4 Substrates
    Mano, Yoko
    Sugiyama, Yuichi
    Ito, Kiyomi
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (09) : 3183 - 3193
  • [9] Effects of drug-drug interactions and CYP3A4 variants on alectinib metabolism
    Ya-nan Liu
    Jie Chen
    Jing Wang
    Qingqing Li
    Guo-xin Hu
    Jian-ping Cai
    Guanyang Lin
    Ren-ai Xu
    Archives of Toxicology, 2023, 97 : 2133 - 2142
  • [10] Effects of drug-drug interactions and CYP3A4 variants on alectinib metabolism
    Liu, Ya-nan
    Chen, Jie
    Wang, Jing
    Li, Qingqing
    Hu, Guo-xin
    Cai, Jian-ping
    Lin, Guanyang
    Xu, Ren-ai
    ARCHIVES OF TOXICOLOGY, 2023, 97 (08) : 2133 - 2142
12345